By Children’s Health Defense Team

The 17 members of the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee who voted 17-0 in favor of authorizing Pfizer’s COVID vaccine for kids ages 5 to 11 all have deep ties to pharma.

The 17 individuals — including an “acting” committee chair and 11 voting members who were temporary rather than core VRBPAC members — formulaically stated the injections’ benefits outweigh the risks in that age group.

Three days later, Dr. Janet Woodcock — a 35-year FDA veteran serving “temporarily” as commissioner — evoked her personal credentials “as a mother and a physician” when she predictably extended Pfizer’s emergency…